Ramsey BW - Search Results

1

Effect of chronic intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis.

Burns JL, Van Dalfsen JM, Shawar RM, Otto KL, Garber RL, Quan JM, Montgomery AB, Albers GM, Ramsey BW, Smith AL. Burns JL, et al. Among authors: ramsey bw. J Infect Dis. 1999 May;179(5):1190-6. doi: 10.1086/314727. J Infect Dis. 1999. PMID: 10191222 Clinical Trial.

2

Predictive value of oropharyngeal cultures for identifying lower airway bacteria in cystic fibrosis patients.

Ramsey BW, Wentz KR, Smith AL, Richardson M, Williams-Warren J, Hedges DL, Gibson R, Redding GJ, Lent K, Harris K. Ramsey BW, et al. Am Rev Respir Dis. 1991 Aug;144(2):331-7. doi: 10.1164/ajrccm/144.2.331. Am Rev Respir Dis. 1991. PMID: 1859056

3

Safety of aerosol tobramycin administration for 3 months to patients with cystic fibrosis.

Smith AL, Ramsey BW, Hedges DL, Hack B, Williams-Warren J, Weber A, Gore EJ, Redding GJ. Smith AL, et al. Among authors: ramsey bw. Pediatr Pulmonol. 1989;7(4):265-71. doi: 10.1002/ppul.1950070413. Pediatr Pulmonol. 1989. PMID: 2515523 Clinical Trial.

4

The effect of respiratory viral infections on patients with cystic fibrosis.

Ramsey BW, Gore EJ, Smith AL, Cooney MK, Redding GJ, Foy H. Ramsey BW, et al. Am J Dis Child. 1989 Jun;143(6):662-8. doi: 10.1001/archpedi.1989.02150180040017. Am J Dis Child. 1989. PMID: 2543212

5

Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group.

Fuchs HJ, Borowitz DS, Christiansen DH, Morris EM, Nash ML, Ramsey BW, Rosenstein BJ, Smith AL, Wohl ME. Fuchs HJ, et al. Among authors: ramsey bw. N Engl J Med. 1994 Sep 8;331(10):637-42. doi: 10.1056/NEJM199409083311003. N Engl J Med. 1994. PMID: 7503821 Free article. Clinical Trial.

6

Clinical manifestations and treatment of pulmonary infections in cystic fibrosis.

Burns JL, Ramsey BW, Smith AL. Burns JL, et al. Among authors: ramsey bw. Adv Pediatr Infect Dis. 1993;8:53-66. Adv Pediatr Infect Dis. 1993. PMID: 8217005 Review. No abstract available.

7

Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis.

Ramsey BW, Astley SJ, Aitken ML, Burke W, Colin AA, Dorkin HL, Eisenberg JD, Gibson RL, Harwood IR, Schidlow DV, et al. Ramsey BW, et al. Am Rev Respir Dis. 1993 Jul;148(1):145-51. doi: 10.1164/ajrccm/148.1.145. Am Rev Respir Dis. 1993. PMID: 8317790 Clinical Trial.

8

Efficacy of aerosolized tobramycin in patients with cystic fibrosis.

Ramsey BW, Dorkin HL, Eisenberg JD, Gibson RL, Harwood IR, Kravitz RM, Schidlow DV, Wilmott RW, Astley SJ, McBurnie MA, et al. Ramsey BW, et al. N Engl J Med. 1993 Jun 17;328(24):1740-6. doi: 10.1056/NEJM199306173282403. N Engl J Med. 1993. PMID: 8497284 Free article. Clinical Trial.

9

A comparison of peak sputum tobramycin concentration in patients with cystic fibrosis using jet and ultrasonic nebulizer systems. Aerosolized Tobramycin Study Group.

Eisenberg J, Pepe M, Williams-Warren J, Vasiliev M, Montgomery AB, Smith AL, Ramsey BW. Eisenberg J, et al. Among authors: ramsey bw. Chest. 1997 Apr;111(4):955-62. doi: 10.1378/chest.111.4.955. Chest. 1997. PMID: 9106575 Clinical Trial.

10

Safety of repeated intermittent courses of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis.

Eisenberg JD, Aitken ML, Dorkin HL, Harwood IR, Ramsey BW, Schidlow DV, Wilmott RW, Wohl ME, Fuchs HJ, Christiansen DH, Smith AL. Eisenberg JD, et al. Among authors: ramsey bw. J Pediatr. 1997 Jul;131(1 Pt 1):118-24. doi: 10.1016/s0022-3476(97)70134-3. J Pediatr. 1997. PMID: 9255202 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

139 results

Search Page